Mpox (Affenpocken)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 370.36 billion USD, with a 24h change of +1.82%. Among 5 constituents, 4 are up (80.00%) and 1 are down (20.00%). The top gainer is GeoVax Labs, Inc. New (GOVX), with a 24h increase of +3.18%.Modest rebound with weak breadth and narrow leadership. Near term, follow liquid leaders; longer term, prioritize clinical/regulatory milestones, balance-sheet strength, and rate sensitivity.
Name
Letzter Preis
Änderung %
Letzter Preis / Änderung %
Chart
Price Range
Aktion
ABT
ABTAbbott Laboratories
105,15$105,15
+1,98 %+$2,05
105,15
+1,98 %
$103,06$105,72
GILD
GILDGilead Sciences Inc
131,56$131,56
+1,72 %+$2,23
131,56
+1,72 %
$129,33$132,51
DGX
DGXQuest Diagnostics Inc.
230,94$230,94
+1,35 %+$3,08
230,94
+1,35 %
$227,86$231,27
CODX
CODXCo-Diagnostics, Inc.
2,05$2,05
-2,38 %-$0,05
2,05
-2,38 %
$1,97$2,13
GOVX
GOVXGeoVax Labs, Inc. New
0,75$0,75
+3,18 %+$0,02
0,75
+3,18 %
$0,70$0,79